95976 ā
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds with one or more PāC bonds; Phosphonic acids RP(=O)(OH); Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se); Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic Esters of aromatic acids (P-C aromatic linkage)
Monomer for Electrolyte, Electrolyte for Secondary Battery Including the Same, Method of Preparing the Same and Lithium Secondary Battery Including the Same
#2METAL EXTRACTANT, SEPARATION RECOVERY METHOD OF METAL IONS USING METAL EXTRACTANT, AND COMPOUND
#3COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
#4BRUSH POLYMER TERMINATED WITH PHOSPHONATE FOR DSA
#5COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
#6PHOPHORUS CONTAINING MONOMER OR OLIGOMER, POLYESTER RESIN COMPRISING SAME, AND THERMOPLASTIC RESIN COMPOSITION
#7Brush polymer terminated with phosphonate for DSA
#8Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#9Surface treatment agent, surface treatment method, and area selective deposition method
#10Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#11Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates
#12STAT3 dimerization inhibitors
#13Sulfur derivatives as chemokine receptor modulators
#14Arabitol and xylitol based flame retardants
#15Flame-retardant vanillin-derived monomers
#16Flame-retardant vanillin-derived small molecules
#17Arabitol and xylitol based flame retardants
#18Bondable flame-retardant vanillin-derived molecules
#19Flame-retardant aconitic acid-derived monomers
#20Supported molybdenum peroxo complexes for transforming organo phosphate neurotoxins to a value-added, commodity phosphorus chemical
#21Dyes with phosphinic acid, phosphinate, phosphonate and phosphonamidate substituents as auxochromic groups and methods for preparing the same
#22STAT3 dimerization inhibitors
#23NOVEL COMPLEXES FOR THE SEPARATION OF CATIONS
#24Sulfur derivatives as chemokine receptor modulators
#25NOVEL COMPLEXES FOR THE SEPARATION OF CATIONS
#26Phosphine ligands for catalytic reactions
#27Transition-metal-free N-arylation of tertiary amines using arynes
#28Sulfur derivatives as chemokine receptor modulators
#29Functionalized naphthalene fluorophores
#30Near-infrared-ray-absorbing composition, near-infrared-ray cut filter using same, manufacturing method therefor, camera module, and manufacturing method therefor
#31Phosphine ligands for catalytic reactions
#32Synthesis, structure and use of functionalized naphthalenes
#33Phosphonate ester derivatives and methods of synthesis thereof
#34POLYSUBSTITUTED ARENES AND SYNTHESIS THEREOF
#35STAT3 dimerization inhibitors
#36High voltage redox shuttles, method for making high voltage redox shuttles
#37Process for preparation of aryl phosphorous compounds
#38Phosphine ligands for catalytic reactions
#39Activators of glucokinase
#40FUSED AROMATIC PHOSPHONATE DERIVATIVES AS PRECURSORS TO PTP-1B INHIBITORS
#41Benzimidazolium compounds
#42Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase
#43CaSR agonists
#44Phosphoric acid esters, their preparation and use
#45Sulfur derivatives as chemokine receptor modulators
#46Phosphonate Ester Derivatives and Methods of Synthesis Thereof
#47(2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators
#48Proton conducting materials
#49Intermediate compounds and process for the preparation of fingolimod
#50Biaryl diphosphine ligands, intermediates of the same and their use in asymmetric catalysis
#51Sulfur derivatives as chemokine receptor modulators
#52Glutamate derivatives or salts thereof
#53Process for the preparation of chymase modulators
#54Proton conducting materials
#55Polyphosphonate, Method of Preparing the Same, and Flame Retardant Thermoplastic Resin Composition Including the Same
#56Sulfur derivatives as chemokine receptor modulators
#57Phosphorous derivatives as chemokine receptor modulators
#58Method for treatment of HIV and diseases of immune dysregulation
#59Phosphonate ester derivatives and methods of synthesis thereof
#60Proton conducting materials
#61PROCESS FOR THE PREPARATION OF ASYMMETRICAL BIS(THIOSEMICARBAZONES)
#62Activators of glucokinase
#63Phosphoric compound, method for preparing the same, and flame retardant thermoplastic resin composition including the same
#64CaSR agonists
#65Production of organic solvent solutions of rare-earth organophosphates
#66Phthalocyanine compound
#67Processes for the preparation of calixarene derivatives
#68PROCESS FOR PRODUCTION OF SUBSTITUTED BENZENE
#69Process for the preparation of chymase modulators
#70Fused heterocyclic compounds as ion channel modulators
#71ORGANOMETAL BENZENEPHOSPHONATE COUPLING AGENTS
#72PROTON CONDUCTING MATERIALS
#73Sterically hindered phenolic phosphonates and polycarbonate resin composition using the same
#74Optically active biaryl phosphorus compound and production process thereof
#75Treatment of HIV and diseases of immune dysregulation
#76Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators
#77Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
#78Substituted picolinamides as MAO-B inhibitors useful for treating obesity
#79Anti-inflammatory phosphonate compounds
#80Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
#81CaSR antagonist
#82Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
#83Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
#84Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
#85Interconnect structure surface modifications by passivating agents